Home
>
National Drug Code (NDC)
>
Paclitaxel
Paclitaxel - 25021-213-17 - (paclitaxel)
Drug Information of Paclitaxel
| Product NDC: | 25021-213 |
| Proprietary Name: | Paclitaxel |
| Non Proprietary Name: | paclitaxel |
| Active Ingredient(s): | 6 mg/mL & nbsp; paclitaxel |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Paclitaxel
| Product NDC: | 25021-213 |
| Labeler Name: | Sagent Pharmaceuticals |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA090130 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20110927 |
Package Information of Paclitaxel
| Package NDC: | 25021-213-17 |
| Package Description: | 1 VIAL in 1 CARTON (25021-213-17) > 16.7 mL in 1 VIAL |
NDC Information of Paclitaxel
| NDC Code | 25021-213-17 |
| Proprietary Name | Paclitaxel |
| Package Description | 1 VIAL in 1 CARTON (25021-213-17) > 16.7 mL in 1 VIAL |
| Product NDC | 25021-213 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | paclitaxel |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20110927 |
| Marketing Category Name | ANDA |
| Labeler Name | Sagent Pharmaceuticals |
| Substance Name | PACLITAXEL |
| Strength Number | 6 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Microtubule Inhibition [PE],Microtubule Inhibitor [EPC] |
